Trial intelligence / Profile preview

Injectable diclofenac dose-ranging study for prevention of post-operative pain after third molar surgery

2012-002996-32Phase 2Completed

Sponsor
IBSA Group
Start
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of diclofenac in postoperative pain (4 arms), sponsored by IBSA Group. Primary endpoint: Primary efficacy endpoint. Started Oct 2012; status: completed.

02

Drugs

diclofenac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2012-002996-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002996-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call